KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other financing activities (2016 - 2022)

Bristol Myers Squibb has reported Other financing activities over the past 14 years, most recently at $179.0 million for Q4 2022.

  • Quarterly Other financing activities rose 6066.67% to $179.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $984.0 million through Dec 2022, up 53.51% year-over-year, with the annual reading at $27.0 million for FY2023, 97.26% down from the prior year.
  • Other financing activities was $179.0 million for Q4 2022 at Bristol Myers Squibb, up from $53.0 million in the prior quarter.
  • Over five years, Other financing activities peaked at $419.0 million in Q2 2022 and troughed at -$58.0 million in Q1 2018.
  • The 5-year median for Other financing activities is $35.5 million (2020), against an average of $103.0 million.
  • Year-over-year, Other financing activities plummeted 1400.0% in 2019 and then skyrocketed 17200.0% in 2020.
  • A 5-year view of Other financing activities shows it stood at $1.0 million in 2018, then plummeted by 1400.0% to -$13.0 million in 2019, then surged by 2230.77% to $277.0 million in 2020, then crashed by 101.08% to -$3.0 million in 2021, then soared by 6066.67% to $179.0 million in 2022.
  • Per Business Quant, the three most recent readings for BMY's Other financing activities are $179.0 million (Q4 2022), $53.0 million (Q3 2022), and $419.0 million (Q2 2022).